The therapeutic range extends to 15 mg
Thousands of Americans have made considerable strides in their weight loss journey using these two options
Phase II clinical trial results demonstrated: Body weight reduction of up to 2% at 48 weeks ( vs 2.1% placebo ) 83% of participants achieved 15% body weight loss at highest dose HbA1c reduction of up to 02% in Type 2 Diabetes participants ( vs 0% placebo ) Normalization of liver fat in 86% of participants with hepatic steatosis Reduction in systolic blood pressure averaging 6-8 mmHg Phase II findings are preliminary
Careful monitoring, potential dosage adjustments, and dietary modifications are key strategies to ensure that Ozempic can be safely and effectively used post-surgery
The FDA had already approved a pill to be used for treating diabetes, but the new development now allows doctors to prescribe the treatment for weight loss to adults with obesity or who are overweight with at least one weight-related comorbidity, such as a heart condition, the company said
This study also showed that levels of choline intake were inversely associated with homocysteine concentrations in the blood